April 28, 2005 — Hyperbaric oxygen (HBO 2) therapy given within six months of hematuria onset is effective for radiation-induced hemorrhagic cystitis, according to the results of a retrospective study ...

PITTSBURGH--(BUSINESS WIRE)--Lipella Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on improving cancer survivorship, today announced it has begun recruiting patients in the ...

PITTSBURGH, April 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (LIPO) (Nasdaq: “LIPO”) (“Lipella,” “our,” “us” or the “Company”), a ...

Late-onset hemorrhagic cystitis (HC) after allogeneic hematopoietic stem cell transplantation (HSCT) has been associated with BK virus (BKV). Antiviral drugs are of limited efficacy and the optimal ...

Please provide your email address to receive an email when new articles are posted on . BK virus-specific cytotoxic T lymphocytes from healthy donors appeared safe and effective for patients with BK ...

I encountered my most memorable patient while working as a urology nurse practitioner at a large urban hospital. The patient was 70 years old, alert and oriented and lived in a nursing home. He had a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The FDA granted orphan drug designation ...

PITTSBURGH--(BUSINESS WIRE)--Lipella Pharmaceuticals Inc., a clinical stage biopharmaceutical company based in Pittsburgh, PA, announced today the investigational new drug (IND) approval for a ...

Posoleucel is being investigated for the treatment and prevention of serious diseases caused by 6 viral pathogens. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ...

DelveInsight's comprehensive analysis reveals robust market expansion driven by growing patient population, emerging therapeutics, and strategic industry developments across major pharmaceutical ...